Dupilumab Biosimilar, Endotoxin 0.05 EU/mg | C104P.05
Dupilumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IgG1 L234A L235A P329G (LALAPG) Fc Silent Mutant. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IgG1 N297A Mutant. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IgG1. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IL4R alpha Monoclonal Antibody. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Evolocumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Evolocumab Biosimilar, Human PCSK9 Monoclonal Antibody. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Eculizumab Biosimilar, Human C5 Monoclonal Antibody. Eculizumab biosimilar CHO stable cell line is available for licensing to manufacture the eculizumab biosimilar protein. The research grade eculizumab biosimilar protein is for research use only (RUO). Recombinant...
Omalizumab Biosimilar, Human IgE Monoclonal Antibody. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human...